176 related articles for article (PubMed ID: 21623989)
1. FTY720-induced conversion of conventional Foxp3- CD4+ T cells to Foxp3+ regulatory T cells in NOD mice.
Sun Y; Wang W; Shan B; Di J; Chen L; Ren L; Li W; Li DJ; Lin Y
Am J Reprod Immunol; 2011 Nov; 66(5):349-62. PubMed ID: 21623989
[TBL] [Abstract][Full Text] [Related]
2. The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro.
Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Huang Y
Int J Mol Med; 2012 Jul; 30(1):211-9. PubMed ID: 22576630
[TBL] [Abstract][Full Text] [Related]
3. The sphingosine 1-phosphate receptor modulator FTY720 prevents iodide-induced autoimmune thyroiditis in non-obese diabetic mice.
Morohoshi K; Osone M; Yoshida K; Nakagawa Y; Hoshikawa S; Ozaki H; Takahashi Y; Ito S; Mori K
Autoimmunity; 2011 Sep; 44(6):490-5. PubMed ID: 21457062
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators.
Sehrawat S; Rouse BT
J Immunol; 2008 Jun; 180(11):7636-47. PubMed ID: 18490766
[TBL] [Abstract][Full Text] [Related]
5. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
Deguchi Y; Andoh A; Yagi Y; Bamba S; Inatomi O; Tsujikawa T; Fujiyama Y
Oncol Rep; 2006 Oct; 16(4):699-703. PubMed ID: 16969482
[TBL] [Abstract][Full Text] [Related]
6. The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo.
Wolf AM; Eller K; Zeiser R; Dürr C; Gerlach UV; Sixt M; Markut L; Gastl G; Rosenkranz AR; Wolf D
J Immunol; 2009 Sep; 183(6):3751-60. PubMed ID: 19692647
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of experimental autoimmune uveitis in mice treated with FTY720.
Commodaro AG; Peron JP; Lopes CT; Arslanian C; Belfort R; Rizzo LV; Bueno V
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2568-74. PubMed ID: 20019358
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of FTY720-treated immature BMDCs significantly prolonged cardiac allograft survival.
Heng Y; Ma Y; Yin H; Duan L; Xiong P; Xu Y; Feng W; Fang M; Tan Z; Chen Y; Zheng F; Gong F
Transpl Int; 2010 Dec; 23(12):1259-70. PubMed ID: 20536794
[TBL] [Abstract][Full Text] [Related]
9. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y
Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676
[TBL] [Abstract][Full Text] [Related]
11. CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia/reperfusion-induced acute kidney injury.
Kim MG; Lee SY; Ko YS; Lee HY; Jo SK; Cho WY; Kim HK
Nephrol Dial Transplant; 2011 Jan; 26(1):111-24. PubMed ID: 20702533
[TBL] [Abstract][Full Text] [Related]
12. Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats.
Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
Exp Neurol; 2009 Mar; 216(1):75-82. PubMed ID: 19100737
[TBL] [Abstract][Full Text] [Related]
13. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.
Kataoka H; Sugahara K; Shimano K; Teshima K; Koyama M; Fukunari A; Chiba K
Cell Mol Immunol; 2005 Dec; 2(6):439-48. PubMed ID: 16426494
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
[TBL] [Abstract][Full Text] [Related]
15. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
16. FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.
Daniel C; Sartory N; Zahn N; Geisslinger G; Radeke HH; Stein JM
J Immunol; 2007 Feb; 178(4):2458-68. PubMed ID: 17277153
[TBL] [Abstract][Full Text] [Related]
17. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs.
Hofmann M; Brinkmann V; Zerwes HG
Int Immunopharmacol; 2006 Dec; 6(13-14):1902-10. PubMed ID: 17161343
[TBL] [Abstract][Full Text] [Related]
18. FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.
Daniel C; Sartory NA; Zahn N; Schmidt R; Geisslinger G; Radeke HH; Stein JM
Mol Immunol; 2007 Jul; 44(13):3305-16. PubMed ID: 17475330
[TBL] [Abstract][Full Text] [Related]
19. FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis.
Fujii R; Kanai T; Nemoto Y; Makita S; Oshima S; Okamoto R; Tsuchiya K; Totsuka T; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G267-74. PubMed ID: 16574986
[TBL] [Abstract][Full Text] [Related]
20. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
